Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Yansheng Wu
Vice President, Global Head of CMC & Regulatory at Hongene Biotech Corporation, USA
Speaker

Profile

With over 20 years of experience in the global biotechnology and pharmaceutical industry, including Bayer, Archemix, Baxter/Baxalta, Shire, Alexion, Sperogenix Therapeutics and Hongene Biotech. Working experience on Analytical Development, GMP compliance, Product Quality, and CMC, from pre-clinical to commercial products. Hands on experience on oligonucleotide. Hold a Ph.D. in Organic Chemistry.

Agenda Sessions

  • Regulatory Strategy for Chemoenzymatic siRNA Manufacturing Process

    , 11:40am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Yansheng at TIDES USA: Oligonucleotide & Peptide Therapeutics